This Week at FDA: FDA names acting CBER director, House committee advances FDA budget bill, and more
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time ...
US Food and Drug Administration Commissioner Marty Makary said the agency should apply the same urgency as it did to approve ...
New clinical trial regulations came into force in the UK this week, marking the biggest change in the law on running human ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
The US Food and Drug Administration (FDA) and representatives from industry have reached an agreement in principle on ...
FDA's Michelle Tarver spoke at the 2026 MedCon Conference (credit: Jeff Craven) COLUMBUS, OH – The US Food and Drug Administration’s (FDA) top medical device official touted her center’s recent ...
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results